Total cholesterol performance of Abell–Levy–Brodie–Kendall reference measurement procedure: Certification of Japanese in-vitro diagnostic assay manufacturers through CDC's Cholesterol Reference Method Laboratory Network
Masakazu Nakamura, Yoshihiro Miyamoto(Asahikawa City Hospital), Yuzo Kayamori(Kyushu University), Michikazu Nakai(National Cerebral and Cardiovascular Center), Hubert W. Vesper(National Center for Environmental Health), Hironori Imano(Kindai University), Hiroyasu Iso(National Center for Global Health and Medicine), Isao Koyama(National Cerebral and Cardiovascular Center), Mahnaz Dasti(Centers for Disease Control and Prevention), Shinji Yokoyama(Chubu University), Tamio Teramoto(Institute for Atherosclerosis Research), Akihiko Kitamura(Ajinomoto (Japan)), Masahiko Kiyama(University of Medicine Tirana), Kunihiro Nishimura(National Cerebral and Cardiovascular Center)
Cited by 27
Related Papers
World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions
|The Lancet Global Health|2019|1.2k
Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017
|Journal of Atherosclerosis and Thrombosis|2018|821
What has made the population of Japan healthy?
|The Lancet|2011|677
Vegetarian Diets and Blood Pressure
|JAMA Internal Medicine|2014|524
Executive Summary of the Japan Atherosclerosis Society (JAS) Guidelines for the Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases in Japan ^|^mdash;2012 Version
|Journal of Atherosclerosis and Thrombosis|2013|469